Joseph Rus
Director/Board Member at BELLUS HEALTH
Joseph Rus active positions
Companies | Position | Start | End |
---|---|---|---|
BELLUS HEALTH | Director/Board Member | 31/05/2009 | - |
Independent Dir/Board Member | 31/05/2009 | - |
Career history of Joseph Rus
Former positions of Joseph Rus
Companies | Position | Start | End |
---|---|---|---|
MERUS LABS INTERNATIONAL INC | Chairman | 11/07/2012 | 08/07/2013 |
Independent Dir/Board Member | 18/12/2011 | 08/07/2013 | |
Shire BioChem, Inc.
Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Chief Executive Officer | 30/04/2001 | - |
President | 30/04/2001 | - | |
Envoy Capital Group, Inc.
Envoy Capital Group, Inc. Advertising/Marketing ServicesCommercial Services Envoy Capital Group, Inc. is a merchant banking company. It provides financial services as well as equity and debt capital to small and mid-cap companies. The firm has two segments: Merchant Banking and Consumer & Retail Branding. The company was founded in December 1993 and is headquartered in Toronto, ON. | Director/Board Member | 30/10/2011 | 18/12/2011 |
Adaltis, Inc.
Adaltis, Inc. Pharmaceuticals: MajorHealth Technology Adaltis, Inc. is an international in-vitro diagnostic company. The company develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases and measure human hormone responses. Adaltis was founded on June 12, 1987 and is headquartered in Montreal, Canada. | Director/Board Member | 31/12/2000 | 01/10/2008 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Corporate Officer/Principal | 31/12/2001 | 22/05/2008 |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands. | Director/Board Member | - | - |
Corporate Officer/Principal | 31/12/1998 | 11/03/2008 | |
United Way of Canada
United Way of Canada Miscellaneous Commercial ServicesCommercial Services United Way of Canada provides leadership, guidance and support services. It works locally to raise funds and invest in improving lives in its community. The company is headquartered in Ottawa, Canada. | Director/Board Member | - | - |
Tanaud International BV
Tanaud International BV Investment Trusts/Mutual FundsMiscellaneous Part of Takeda Pharmaceutical Co., Ltd., Tanaud International BV provides open-end investment management services. The company is based in Amsterdam, Netherlands. | Director/Board Member | - | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░ ░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Statistics
International
Canada | 13 |
United Kingdom | 2 |
Italy | 2 |
Operational
Director/Board Member | 12 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 8 |
Commercial Services | 5 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 16 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Shire BioChem, Inc.
Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Distribution Services |
Adaltis, Inc.
Adaltis, Inc. Pharmaceuticals: MajorHealth Technology Adaltis, Inc. is an international in-vitro diagnostic company. The company develops, manufactures and markets in-vitro diagnostic systems and reagent products to detect viral infections, diagnose immune system diseases and measure human hormone responses. Adaltis was founded on June 12, 1987 and is headquartered in Montreal, Canada. | Health Technology |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands. | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Shire Canada, Inc.
Shire Canada, Inc. Pharmaceuticals: MajorHealth Technology Shire Canada, Inc. develops and markets medicines. It focuses on attention deficit hyperactivity disorder (ADHD), rare diseases, as well as gastrointestinal and renal diseases. The firm develops treatments for genetic disorders known as rare or orphan diseases. The company was founded in 1986 and is headquartered in Saint-Laurent, Canada. | Health Technology |
Envoy Capital Group, Inc.
Envoy Capital Group, Inc. Advertising/Marketing ServicesCommercial Services Envoy Capital Group, Inc. is a merchant banking company. It provides financial services as well as equity and debt capital to small and mid-cap companies. The firm has two segments: Merchant Banking and Consumer & Retail Branding. The company was founded in December 1993 and is headquartered in Toronto, ON. | Commercial Services |
Merus Labs International, Inc.
Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
ViroChem Pharma, Inc.
ViroChem Pharma, Inc. Pharmaceuticals: MajorHealth Technology ViroChem Pharma, Inc. provides antiviral drug research and development services. The company provides R&D services on HIV/AIDS and hepatitis C. It was founded on April 8, 2004 and is headquartered in Laval, Canada. | Health Technology |
Centraide of Greater Montreal
Centraide of Greater Montreal Miscellaneous Commercial ServicesCommercial Services Centraide of Greater Montreal supports community agencies in the neighbourhoods. It has four areas of action: supporting youth, providing basic needs, helping the socially isolated and bringing communities together. The company was founded in 1966 and is headquartered in Montr?al, Canada. | Commercial Services |
Glaxosmithkline Shire, Inc. | |
Shire Italia SpA
Shire Italia SpA Medical/Nursing ServicesHealth Services Shire Italia SpA provides healthcare services. It offers processing of drugs in pharmaceutical preparations for human or veterinary use. The company is headquartered in milan, Italy. | Health Services |
Shire Pharmaceuticals Mexico SA de CV
Shire Pharmaceuticals Mexico SA de CV Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Mexico SA de CV develops and markets drugs for the treatment of low frequency diseases. The company is based in Cuajimalpa, Mexico. | Health Technology |
3829359 Canada, Inc. | |
Tanaud International BV
Tanaud International BV Investment Trusts/Mutual FundsMiscellaneous Part of Takeda Pharmaceutical Co., Ltd., Tanaud International BV provides open-end investment management services. The company is based in Amsterdam, Netherlands. | Miscellaneous |
United Way of Canada
United Way of Canada Miscellaneous Commercial ServicesCommercial Services United Way of Canada provides leadership, guidance and support services. It works locally to raise funds and invest in improving lives in its community. The company is headquartered in Ottawa, Canada. | Commercial Services |
- Stock Market
- Insiders
- Joseph Rus
- Experience